Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
CMND
CMND
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CMND News
Clearmind Medicine Reports Positive Clinical Trial Results
6d ago
NASDAQ.COM
Clearmind Reports Positive Safety Results for AUD Drug in Phase I/IIa Trial
6d ago
Newsfilter
Cannabis Sector Update: Aurora's Strategic Shift Amid Record Medical Sales
Feb 08 2026
Yahoo Finance
Clearmind Regains Nasdaq Compliance with Share Price Above $1
Dec 31 2025
Globenewswire
Clearmind Regains Nasdaq Compliance with Share Price Above $1
Dec 31 2025
Newsfilter
Clearmind Medicine Advances CMND-100 Clinical Trials for Alcohol Use Disorder
Dec 24 2025
Globenewswire
Clearmind Completes Patient Enrollment for Second Cohort of CMND-100 Trial
Dec 16 2025
Newsfilter
Clearmind Publishes Review on MEAI's Potential in Alcohol Use Disorder Treatment
Dec 12 2025
Newsfilter
Clearmind Regains Nasdaq Compliance with $2.5M Stockholders' Equity
Dec 12 2025
Newsfilter
Planet Labs Shares Rise Approximately 16%; Check Out 20 Stocks Making Moves in Premarket Trading
Dec 11 2025
Benzinga
Clearmind Medicine Set to Execute 1-for-40 Reverse Stock Split Next Week
Dec 11 2025
NASDAQ.COM
What Caused Clearmind Medicine's Shares to Drop 29% in After-Hours Trading?
Dec 11 2025
Benzinga
Clearmind Medicine Inc. Executes 1-for-40 Reverse Stock Split to Comply with Nasdaq Rules
Dec 10 2025
Globenewswire
Clearmind Medicine Declares 1-for-40 Reverse Stock Split
Dec 10 2025
Yahoo Finance
Clearmind Medicine Faces Nasdaq Compliance Issue as Share Price Falls Below $1
Dec 05 2025
Globenewswire
Clearmind Medicine Receives 180-Day Compliance Period from Nasdaq Due to Low Share Price
Dec 05 2025
Newsfilter
Show More News
